Dominari Holdings Inc.

NasdaqCM:DOMH Stock Report

Market Cap: US$55.4m

Dominari Holdings Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Dominari Holdings.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Capital Markets earnings growth12.1%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Analysis Article Aug 23

Dominari Holdings Inc. (NASDAQ:DOMH) Shares Fly 26% But Investors Aren't Buying For Growth

Dominari Holdings Inc. ( NASDAQ:DOMH ) shares have continued their recent momentum with a 26% gain in the last month...
Analysis Article Jun 30

Subdued Growth No Barrier To Dominari Holdings Inc. (NASDAQ:DOMH) With Shares Advancing 26%

Dominari Holdings Inc. ( NASDAQ:DOMH ) shares have continued their recent momentum with a 26% gain in the last month...
Analysis Article Feb 12

What Dominari Holdings Inc.'s (NASDAQ:DOMH) 584% Share Price Gain Is Not Telling You

Dominari Holdings Inc. ( NASDAQ:DOMH ) shareholders would be excited to see that the share price has had a great month...
Analysis Article Dec 29

Little Excitement Around Dominari Holdings Inc.'s (NASDAQ:DOMH) Revenues As Shares Take 32% Pounding

The Dominari Holdings Inc. ( NASDAQ:DOMH ) share price has fared very poorly over the last month, falling by a...
Seeking Alpha Oct 05

AIkido continues to buyback more shares

AIkido Pharma (NASDAQ:AIKI) reported that on October 4, 2022, the company purchased 38,035 shares of common stock at $6.99/share  The buyback is part of the company's share repurchase program authorized by the company's Board on January 21, 2022. "We believe the Company stock continues to be undervalued and we are using this opportunity to enhance shareholder value by reducing the amount of stock that is outstanding." said Anthony Hayes, CEO
Seeking Alpha Sep 12

AIkido Pharma's subsidiary agrees to buy broker-dealer firm

Dominari Financial, the financial services subsidiary of AIkido Pharma (NASDAQ:AIKI) agrees to acquire a broker-dealer firm. It is Dominari's first acquisition since launching in June. Dominari Financial was formed with the intention of acquiring revenue generating assets in the fintech and financial services industry. The move will accelerate growth strategy. Kyle Wool, AIkido board member, acted as matchmaker on the deal and will continue to advise Mr. Aldavero on the purchase. The move will allow Dominari Financial to provide banking and lending services through a collaborative pact with a third-party institution, delivering the full balance sheet to UHNW investors, corporations, and institutional clients once the deal officially closes.
Seeking Alpha Aug 09

Alkido Pharma shareholders proposes to acquire company at $8/share in cash

Alkido Pharma's (NASDAQ:AIKI) significant stockholder Shalom Auerbach, who owns ~3.8% of its stock, announced that he has sent a letter proposing to acquire the company for $8/share in cash. This proposal to buy AIKI represents a 31% premium to the company’s most recent closing share price on Aug.8, 2022. It will provide substantial and immediate cash value for stockholders. The shareholder indicates that he will not hold this proposal open indefinitely and it is critical that the company meets with him by no later than Aug.23, 2022.
Analysis Article May 04

AIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth Plans

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Seeking Alpha Feb 10

AIkido Pharma: Advancing Anticancer And Antiviral Therapies

AIkido Pharma is advancing anticancer and antiviral therapies backed by strong IP. The Company also invests in non-core businesses that contribute near-term monetization. The Company is flush with cash and has offered to buy back $3 million of shares.
Analysis Article Jan 14

AIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth Plans

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article Sep 29

Here's Why We're Not Too Worried About AIkido Pharma's (NASDAQ:AIKI) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article Jun 05

We Think AIkido Pharma (NASDAQ:AIKI) Can Easily Afford To Drive Business Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dominari Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqCM:DOMH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2026152-47-7-7N/A
12/31/2025123-222323N/A
9/30/2025102110-9-9N/A
6/30/202555-19-9-9N/A
3/31/202527-42-7-7N/A
12/31/202421-15-17-17N/A
9/30/202413-23-17-17N/A
6/30/202410-22-16-16N/A
3/31/20243-25-27-27N/A
12/31/20232-23-23-22N/A
9/30/20231-23-21-19N/A
6/30/20230-26-21-19N/A
3/31/2023N/A-23-13-11N/A
12/31/2022N/A-26-12-11N/A
9/30/2022N/A-21-11-11N/A
6/30/2022N/A-15-10-10N/A
3/31/2022N/A-10-9-9N/A
12/31/2021N/A-7-7-7N/A
9/30/2021N/A-5-6-5N/A
6/30/2021N/A-7-5-4N/A
3/31/2021N/A-8-5-4N/A
12/31/2020N/A-12-5-4N/A
9/30/20200-12-6-4N/A
6/30/20200-13-5-4N/A
3/31/20200-11-5-4N/A
12/31/20190-4N/A-3N/A
9/30/201900N/A-3N/A
6/30/201902N/A-3N/A
3/31/201902N/A-3N/A
12/31/201802N/A-3N/A
9/30/20180-5N/A-3N/A
6/30/20181-2N/A-3N/A
3/31/20181-4N/A-4N/A
12/31/20171-3N/A-3N/A
9/30/20171-6N/A-3N/A
6/30/20171-7N/A-4N/A
3/31/2017125N/A1N/A
12/31/2016125N/A0N/A
9/30/2016134N/A0N/A
6/30/2016031N/A0N/A
3/31/20160-39N/A-5N/A
12/31/20150-42N/A-5N/A
9/30/20150-53N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if DOMH's forecast earnings growth is above the savings rate (3.7%).

Earnings vs Market: Insufficient data to determine if DOMH's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if DOMH's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if DOMH's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if DOMH's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if DOMH's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/10 15:38
End of Day Share Price 2026/08/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dominari Holdings Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vernon BernardinoH.C. Wainwright & Co.